Mucositis
References

1. Aisa, Y, Mori,T., K., Yashima, T., Kondo, S., Yokoyama, A., Ikeda, Y., & Okamoto. (2005) Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care In Cancer 13, 266-269.
2. Buchsel, P.C. (2003) Gelclairâ Oral Gel, Clinical Journal of Oncology Nursing 7(1), 109-110
3. Eilers, J.(2004). "Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment", Oncology Nursing Forum, 31(4)Suppl, 13-23
4. Oral Health, Cancer Care and You: Fitting the Pieces Together, US Dept of Health and Human Services, NIH Pub #99-4372.
5. Rocke, L.K., Loprinzi, C.L., Lee, J.K., Kunselman,S.J., Iverson, R.K., Finck, G., Kifsey, D., Glaw, K.C., Stevens, B.A., Hatfield, A.K., Vaught, N.L., Bartel, J., & Pierson, N., (1993). A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer 72, 2234-8.
6. Samuels, M.A. (2004). Cytoprotection in Head and Neck Cancer: Issues in Oral Care. The Journal of Supportive Oncology 2(6), Suppl 3, 9-12.
7. Sonis, S. T. (2004) Oral Mucositis in Cancer therapy. The Journal of Supportive Oncology 2(6), Suppl 3, 3-8.
8. Spielberger R, Stiff P, Bensinger W, et al.: Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine, 351(25), 2590-8, 2004.